Atlas Trials

Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

Clinical trial NCT01333124 · TERMINATED

Trial details

NCT number
NCT01333124
Sponsor
National Cancer Center, Korea
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Resectable Pancreatic Carcinoma
Start date
2011-09-28
Primary completion
2017-12-31
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.